Literature DB >> 22249417

Comprehensive two-dimensional gas chromatography in metabolomics.

Martin F Almstetter1, Peter J Oefner, Katja Dettmer.   

Abstract

One of the major objectives in metabolomics is the identification of subtle changes in metabolite profiles as affected by genetic or environmental factors. Comprehensive two-dimensional gas chromatography (GC × GC) hyphenated to a fast-acquisition mass spectrometer is a well-established analytical technique to study the composition of complex samples due to its enhanced separation capacity, sensitivity, peak resolution, and reproducibility. This review reports applications of GC × GC to metabolomics studies of sample of different types (biofluid, cells, tissue, bacteria, yeast, plants), and discusses its advantages and limitations.

Entities:  

Mesh:

Year:  2012        PMID: 22249417     DOI: 10.1007/s00216-011-5630-y

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  16 in total

1.  Discovery of new modules in metabolic biology using ChemoMetabolomics.

Authors:  Samuel Bocobza; Lothar Willmitzer; Natasha V Raikhel; Asaph Aharoni
Journal:  Plant Physiol       Date:  2012-09-06       Impact factor: 8.340

2.  Improving the quality of biomarker candidates in untargeted metabolomics via peak table-based alignment of comprehensive two-dimensional gas chromatography-mass spectrometry data.

Authors:  Heather D Bean; Jane E Hill; Jean-Marie D Dimandja
Journal:  J Chromatogr A       Date:  2015-03-07       Impact factor: 4.759

3.  Breath analysis by two-dimensional gas chromatography with dual flame ionisation and mass spectrometric detection - Method optimisation and integration within a large-scale clinical study.

Authors:  Michael J Wilde; Rebecca L Cordell; Dahlia Salman; Bo Zhao; Wadah Ibrahim; Luke Bryant; Dorota Ruszkiewicz; Amisha Singapuri; Robert C Free; Erol A Gaillard; Caroline Beardsmore; C L Paul Thomas; Chris E Brightling; Salman Siddiqui; Paul S Monks
Journal:  J Chromatogr A       Date:  2019-02-05       Impact factor: 4.759

4.  Integrating comprehensive two-dimensional gas chromatography mass spectrometry and parallel two-dimensional liquid chromatography mass spectrometry for untargeted metabolomics.

Authors:  Md Aminul Islam Prodhan; Biyun Shi; Ming Song; Liqing He; Fang Yuan; Xinmin Yin; Patrick Bohman; Craig J McClain; Xiang Zhang
Journal:  Analyst       Date:  2019-06-13       Impact factor: 4.616

5.  Electron Ionization-Induced Release of Coded Isotopic Reporter Ions in an m/z Zone of Minimal Interference for Quantifiable, Multiplexed GC-MS Analyses.

Authors:  Sébastien Laulhé; Tyler E Geers; Xue Shi; Xiang Zhang; Michael H Nantz
Journal:  Anal Methods       Date:  2013-09-21       Impact factor: 2.896

Review 6.  Linking metabolomics data to underlying metabolic regulation.

Authors:  Thomas Nägele
Journal:  Front Mol Biosci       Date:  2014-11-06

Review 7.  Two birds with one stone: doing metabolomics with your proteomics kit.

Authors:  Roman Fischer; Paul Bowness; Benedikt M Kessler
Journal:  Proteomics       Date:  2013-11-21       Impact factor: 3.984

8.  Complementary use of GCxGC-TOF-MS and statistics for differentiation of variety in biosolid samples.

Authors:  Hubert Byliński; Tomasz Dymerski; Jacek Gębicki; Jacek Namieśnik
Journal:  Monatsh Chem       Date:  2018-08-09       Impact factor: 1.451

9.  Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study.

Authors:  José Marcos Sanches; Paulo César Giraldo; Rose Amaral; Marcos Nogueira Eberlin; Lygia Azevedo Marques; Isabel Migliorini; Marcel Nakahira; Michel Jan Marinus Bieleveld; Michelle Garcia Discacciati
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

10.  Advances in gas chromatographic methods for the identification of biomarkers in cancer.

Authors:  Konstantinos A Kouremenos; Mikael Johansson; Philip J Marriott
Journal:  J Cancer       Date:  2012-09-26       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.